The FDA approved Roche Diagnostics and Eli Lilly’s blood test to help doctors assess Alzheimer’s disease in people 55 and ...

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...

The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...

Earlier menopause may be associated with faster cognitive decline and an earlier Alzheimer’s disease diagnosis. Researchers ...

Nevada Rural Counties RSVP Program, Inc. (RSVP) is pleased to announce that Chief Executive Officer Molly Walt has been ...

The findings documented here are interesting and valuable with respect to revealing genetic players that may underlie AD. However, there are concerns related to the analysis pipeline and the basic ...

The FDA has approved a blood test developed by Roche to detect Alzheimer's disease in adults 55 and older experiencing cognitive loss, offering a less invasive diagnostic option.

In this episode titled, 'Alzheimer's Disease Prevalence and Prevention: Building the Case for Early Diagnosis,' Kavita Nair, PhD ...

When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning ...

Poor sleep quality has been linked to cognitive decline, neurodegeneration and Alzheimer's disease in older adults. A new ...

Re “New Potential for Diagnosing Alzheimer’s Disease” (Science Times, July 21): Blood-based detection of Alzheimer’s would do more than change how the disease is diagnosed. It could catch the disease ...